Name: UMIN ID:
| Unique ID issued by UMIN | UMIN000011048 |
|---|---|
| Receipt number | R000012931 |
| Scientific Title | Phase II study of Nab-paclitaxel followed by FEC as neoadjuvant chemotherapy for the operable breast cancer |
| Date of disclosure of the study information | 2013/06/26 |
| Last modified on | 2019/02/04 18:16:36 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/06/26 18:38:52 | ||
| 2 | Update | 2019/01/23 09:47:07 | UMIN ID1 |
|
| 3 | Update | 2019/02/04 18:16:36 | Recruitment status Date of closure to data entry |